Dihydrodiol-ibrutinib is intended for Pharmaceuticals applications; it's a metabolite of Ibrutinib, a Bruton's tyrosine kinase inhibitor used as an oral treatment for certain leukemias. All information about Dihydrodiol-ibrutinib is provided in the MSDS. We deliver compounds with high purity levels and a comprehensive Certificate of Analysis. Connect to your member account to consult the documents.

规格	1 mg
稳定性	≥ 1 year